P3 Health Partners Stock Performance
| PIII Stock | USD 6.78 0.16 2.31% |
The firm owns a Beta (Systematic Risk) of 0.16, which implies not very significant fluctuations relative to the market. As returns on the market increase, P3 Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding P3 Health is expected to be smaller as well. At this point, P3 Health Partners has a negative expected return of -0.14%. Please make sure to check P3 Health's standard deviation, kurtosis, relative strength index, as well as the relationship between the maximum drawdown and day median price , to decide if P3 Health Partners performance from the past will be repeated sooner or later.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days P3 Health Partners has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest inconsistent performance, the Stock's forward indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders. ...more
Actual Historical Performance (%)
One Day Return (2.40) | Five Day Return (0.07) | Year To Date Return 2.6 K | Ten Year Return (30.02) | All Time Return (30.02) |
Last Split Factor 1:50 | Last Split Date 2025-04-14 |
1 | Acquisition by Chicago Pacific Founders Ugp Iii, Llc of 1428129 shares of P3 Health at 10.34 subject to Rule 16b-3 | 06/04/2025 |
2 | Wolf Haldenstein Adler Freeman Herz LLP is investigating P3 Health Partners, Inc. | 06/06/2025 |
3 | Trading Halted for P3 Health Partners Amid Market Volatility - AInvest | 07/30/2025 |
4 | MDxHealth SA Reports Q2 Loss, Tops Revenue Estimates | 08/06/2025 |
5 | P3 Health Q2 2025 Earnings Call Transcript | 08/14/2025 |
| Begin Period Cash Flow | 40.9 M | |
| Total Cashflows From Investing Activities | 14.5 M | |
| Free Cash Flow | -110.1 M |
P3 Health Relative Risk vs. Return Landscape
If you would invest 794.00 in P3 Health Partners on May 18, 2025 and sell it today you would lose (116.00) from holding P3 Health Partners or give up 14.61% of portfolio value over 90 days. P3 Health Partners is currently does not generate positive expected returns and assumes 4.9943% risk (volatility on return distribution) over the 90 days horizon. In different words, 44% of stocks are less volatile than PIII, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
P3 Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for P3 Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as P3 Health Partners, and traders can use it to determine the average amount a P3 Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0275
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PIII |
Estimated Market Risk
| 4.99 actual daily | 44 56% of assets are more volatile |
Expected Return
| -0.14 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average P3 Health is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of P3 Health by adding P3 Health to a well-diversified portfolio.
P3 Health Fundamentals Growth
PIII Stock prices reflect investors' perceptions of the future prospects and financial health of P3 Health, and P3 Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on PIII Stock performance.
| Return On Equity | -1.2 | ||||
| Return On Asset | -0.24 | ||||
| Profit Margin | (0.09) % | ||||
| Operating Margin | (0.10) % | ||||
| Current Valuation | 165.5 M | ||||
| Shares Outstanding | 3.27 M | ||||
| Price To Book | 0.36 X | ||||
| Price To Sales | 0.95 X | ||||
| Revenue | 1.5 B | ||||
| Gross Profit | (64.17 M) | ||||
| EBITDA | (197.76 M) | ||||
| Net Income | (310.38 M) | ||||
| Cash And Equivalents | 63.15 M | ||||
| Cash Per Share | 1.52 X | ||||
| Total Debt | 166.16 M | ||||
| Debt To Equity | 0.08 % | ||||
| Current Ratio | 0.75 X | ||||
| Book Value Per Share | 19.38 X | ||||
| Cash Flow From Operations | (110.13 M) | ||||
| Earnings Per Share | (52.42) X | ||||
| Market Capitalization | 1.41 B | ||||
| Total Asset | 783.42 M | ||||
| Retained Earnings | (503.19 M) | ||||
| Working Capital | (312.27 M) | ||||
About P3 Health Performance
By evaluating P3 Health's fundamental ratios, stakeholders can gain valuable insights into P3 Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if P3 Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if P3 Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 0.34 | 0.35 | |
| Return On Tangible Assets | (0.65) | (0.68) | |
| Return On Capital Employed | (1.09) | (1.14) | |
| Return On Assets | (0.17) | (0.18) | |
| Return On Equity | (1.79) | (1.88) |
Things to note about P3 Health Partners performance evaluation
Checking the ongoing alerts about P3 Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for P3 Health Partners help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| P3 Health Partners generated a negative expected return over the last 90 days | |
| P3 Health Partners has high historical volatility and very poor performance | |
| P3 Health Partners currently holds 166.16 M in liabilities with Debt to Equity (D/E) ratio of 0.08, which may suggest the company is not taking enough advantage from borrowing. P3 Health Partners has a current ratio of 0.74, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about P3 Health's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 1.5 B. Net Loss for the year was (310.38 M) with loss before overhead, payroll, taxes, and interest of (64.17 M). | |
| P3 Health Partners currently holds about 63.15 M in cash with (110.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.52. | |
| Roughly 62.0% of P3 Health outstanding shares are owned by corporate insiders | |
| Latest headline from fool.com: P3 Health Q2 2025 Earnings Call Transcript |
- Analyzing P3 Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether P3 Health's stock is overvalued or undervalued compared to its peers.
- Examining P3 Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating P3 Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of P3 Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of P3 Health's stock. These opinions can provide insight into P3 Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for PIII Stock analysis
When running P3 Health's price analysis, check to measure P3 Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy P3 Health is operating at the current time. Most of P3 Health's value examination focuses on studying past and present price action to predict the probability of P3 Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move P3 Health's price. Additionally, you may evaluate how the addition of P3 Health to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |